Evaluation of the Effects of a Novel Nicotinic Agonist, AZD1446, on Neurochemical and Electrophysiologic Endpoints in DYT1 Mouse Models.

Grant

Total Award Amount

  • 50000.00
  • Direct Costs

  • 50000.00
  • Sponsor Award Id

  • Contributor

  • David Standaert   Principal Investigator